Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that Functional Hypothalamic Amenorrhea should be carefully diagnosed and managed to prevent health complications, using lifestyle changes and specific medications.

Dutasteride may help protect neurons and reduce inflammation in Parkinson's disease.

COVID-19 patients may experience temporary hair loss, mainly in women, which is likely reversible.

Hair growth supplements do not reduce the effectiveness of the breast cancer treatment tamoxifen.

Menopause reduces skin collagen and elasticity, and while estrogen therapy can help, its risks require careful consideration.

The study found specific proteins that could mark different growth stages of cashmere goat hair and may help improve cashmere production.

Estetrol may help prevent hair loss and promote hair growth in women.

Darker skin in 10-year-old girls may be an early sign of puberty.

Transdermal testosterone can improve sexual desire in postmenopausal women but lacks long-term safety data and is not FDA-approved for this use.

Menopause and aging can affect women's quality of life and sexuality, but hormone therapies may help alleviate these issues.

A woman had a rare liver tumor causing male-like physical changes, highlighting the need for thorough checks when such symptoms appear.

The commentary suggests that certain hair and skin care products may be linked to frontal fibrosing alopecia, but not sunscreens, and calls for more thorough research on the causes.

Smoking may contribute to hair loss in men.

Amenorrhea is relatively rare and initial testing should check FSH, TSH, and prolactin levels.

Taking metformin with intense-pulsed-light therapy improves hair removal for people with PCOS.

Testosterone therapy can improve sexual satisfaction and mood in surgically menopausal women when used with estrogen, but its long-term safety and effects on naturally menopausal and premenopausal women are unclear.

Treatments for hair loss include estrogen therapy and special shampoos.

The conclusion is to diagnose PCOS with just hyperandrogenism and irregular periods, and treat with lifestyle changes and basic medications.

The document concludes that identifying the cause of amenorrhea is crucial for proper treatment.

The document concludes that non-operative treatment for gender dysphoria is safe and effective, and hormone therapy does not increase cancer risk.

Testosterone may slow down wound healing and increase inflammation.

A transwoman developed a brain tumor after nine years of hormone therapy, suggesting a possible link between the treatment and tumor development.

The document concludes that treating female hair loss should target reducing excess androgen and blocking its effects on hair follicles, with the best treatments being hormonal therapy, adrenal suppression, and topical minoxidil.

Changes in testosterone and estrogen receptor genes can affect how men age, influencing body fat, hair patterns, and possibly leading to skin disorders.

Men with male-pattern baldness have more androgen receptors in their scalp's oil glands, which may contribute to hair loss.

The study suggests certain ACE gene variations are more common in women with PCOS and may be linked to increased insulin resistance.

Menopausal women have higher androgen levels, which can cause symptoms like facial hair growth and low sexual desire.

A young woman with kidney failure had hair loss due to a common hormonal disorder, which improved with hormone therapy.

Women with polycystic ovary syndrome have a higher risk of certain fractures.

An 86-year-old man with prostate cancer was diagnosed with a rare, low-grade breast cancer and underwent surgery but declined additional hormone therapy.